residual 1
disease 1
novel 1
xenograft 1
model 1
runxmutated 1
cytogenetically 1
normal 1
acute 2
myeloid 2
leukemia 2
pharmacological 1
targeting 1
mir 1
neddactivating 1
enzyme 1
inhibitor 1
mln 1
pevonedistat 1
fltitd 1
extracellular 1
crystals 1
plasma 1
cell 1
myeloma 1
salvage 1
therapy 1
hodgkins 2
lymphoma 2
bortezomib 1
gemcitabine 1
relapsed 1
refractory 1
